MedTrace Logo

Condensed Nanofat Grafting for Treatment of Androgenetic Alopecia

NCT03506503 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2021-02-21

No results posted yet for this study

Summary

Nowadays, multiple treatment modalities have been applied clinically to treat androgenic alopecia, such as Follicular unit transplantation(FUT), finasteride, platelet-rich plasma injection(PRP), etc. In this clinical trial, the investigators aim to analyze the effect of nanofat grafting on treating androgenic alopecia in male.

Conditions

  • Androgenic Alopecia

Interventions

PROCEDURE

Nanofat grafting

hair loss area will be treated by processed autologous Nanofat grafting

Sponsors & Collaborators

  • Jinan University Guangzhou

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-27
Primary Completion
2020-02-27
Completion
2020-05-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03506503 on ClinicalTrials.gov